Tabebuia impetiginosa

Ethnobotanical Studies

Studies

LC-qTOF-MS/MS phytochemical profiling of Tabebuia impetiginosa (Mart. Ex DC.) Standl. leaf and assessment of its neuroprotective potential in rats.

Summary

Researchers studied Tabebuia impetiginosa for its traditional uses of memory enhancement and CNS stimulation, providing potential insight for neurological research and drug development.

NeurosciencePhytochemistry
Khaled N et al (2024).
J Ethnopharmacol.
DOI:
10.1016/j.jep.2024.118292
PubMed:
38705428

Safety and tolerability of Pau d' Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18-45.

McClure C et al (2022).
Adv Integr Med.
DOI:
10.1016/j.aimed.2022.04.003
PubMed:
36960315

Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.

Summary

Researchers studied whether Tabebuia impetiginosa bark could be used to treat Parkinson's disease. This bark has been used as a tonic and for motor disorders. The study used experimental methods to explore its activity in treating Parkinson's.

Neuroscience
Pal Roy S et al (2022).
Ann Pharm Fr.
DOI:
10.1016/j.pharma.2022.02.007
PubMed:
35240121

The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes.

Immunology
Ryan RYM et al (2021).
Sci Rep.
DOI:
10.1038/s41598-021-85211-8
PubMed:
33750911

Development and Validation of an Analytical Method Readily Applicable for Quality Control of Tabebuia impetiginosa (Taheebo) Ethanolic Extract.

Jin Y et al (2018).
J AOAC Int.
DOI:
10.5740/jaoacint.17-0228
PubMed:
28927490

Lapachol and lapachone analogs: a journey of two decades of patent research(1997-2016).

Review
Hussain H and Green IR (2017).
Expert Opin Ther Pat.
DOI:
10.1080/13543776.2017.1339792
PubMed:
28586252

β-Lapachone Inhibits Lung Metastasis of Colorectal Cancer by Inducing Apoptosis of CT26 Cells.

Cancer
Kee JY et al (2017).
Integr Cancer Ther.
DOI:
10.1177/1534735416681638
PubMed:
27923905

Bioactive Properties of Tabebuia impetiginosa-Based Phytopreparations and Phytoformulations: A Comparison between Extracts and Dietary Supplements.

Pires TC et al (2015).
Molecules.
DOI:
10.3390/molecules201219885
PubMed:
26703544

Assessing the extent of "conflict of use" in multipurpose tropical forest trees: a regional view.

Herrero-Jáuregui C et al (2013).
J Environ Manage.
DOI:
10.1016/j.jenvman.2013.08.044
PubMed:
24061084

A coupled phylogeographical and species distribution modelling approach recovers the demographical history of a Neotropical seasonally dry forest tree species.

Collevatti RG et al (2012).
Mol Ecol.
DOI:
10.1111/mec.12071
PubMed:
23094833

Lapacho tea (Tabebuia impetiginosa) extract inhibits pancreatic lipase and delays postprandial triglyceride increase in rats.

Kiage-Mokua BN, Roos N and Schrezenmeir J (2012).
Phytother Res.
DOI:
10.1002/ptr.4659
PubMed:
22431070

Modulatory effects of Tabebuia impetiginosa (Lamiales, Bignoniaceae) on doxorubicin-induced somatic mutation and recombination in Drosophila melanogaster.

de Sousa NC et al (2009).
Genet Mol Biol.
DOI:
10.1590/S1415-47572009005000042
PubMed:
21637695

Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity?

Review Ethnobotany
Gómez Castellanos JR, Prieto JM and Heinrich M (2009).
J Ethnopharmacol.
DOI:
10.1016/j.jep.2008.10.004
PubMed:
18992801

Constituents from the bark of Tabebuia impetiginosa.

Warashina T, Nagatani Y and Noro T (2006).
Chem Pharm Bull (Tokyo).
PubMed:
16394542

Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.

Park BS et al (2006).
J Ethnopharmacol.
PubMed:
16359837

Further constituents from the bark of Tabebuia impetiginosa.

Warashina T, Nagatani Y and Noro T (2005).
Phytochemistry.
PubMed:
15721952